Literature DB >> 17076637

Chemical and biological factors in the control of Brucella and brucellosis.

Carlos Gamazo1, María Concepción Lecároz, Sandra Prior, Ana Isabel Vitas, Miguel Angel Campanero, Juan Manuel Irache, María José Blanco-Prieto.   

Abstract

Brucellosis is a highly contagious bacterial zoonosis that affects millions of people worldwide. Brucella is highly infectious, especially when aerosolized. The infection induces severe protracted diseases, which are both debilitating and incapacitating, hence, Brucella melitensis has been considered a potential biological warfare agent. In the battle against Brucella, it is crucial to know its chemical-structure and biochemistry-metabolic characteristics. It is well known that Brucella, as well as many other intracellular bacterial pathogens, has evolved to survive and even proliferate within monocytes and macrophages cells. Depending on the route of entry (complement, Fc, lectin or fibronectin receptors), the fate of the bacteria will vary; it may even segregate from the endocytic route towards the endoplasmic reticulum. This intracellular "non regular" behaviour of Brucella makes treatment difficult. Most antibiotics, although effective in vitro, do not actively pass through cellular membranes, or, once inside, may not reach the discrete intracellular niche where the bacteria is hidden. Therefore, complete eradication of the microorganisms is difficult to achieve, and the incidence of relapses is rather high. Taking these data into consideration, this review will evaluate the past, current and new trends in the control of brucellosis, paying special attention to the drug delivery systems as potential vectors for targeting these intracellular sites where the organisms are located.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17076637     DOI: 10.2174/156720106778559038

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  6 in total

1.  Efficacy of amphiphilic core-shell nanostructures encapsulating gentamicin in an in vitro salmonella and listeria intracellular infection model.

Authors:  A Ranjan; N Pothayee; T P Vadala; M N Seleem; E Restis; N Sriranganathan; J S Riffle; R Kasimanickam
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

2.  Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.

Authors:  Edurne Imbuluzqueta; Carlos Gamazo; Hugo Lana; Miguel Ángel Campanero; David Salas; Ana Gloria Gil; Elisa Elizondo; Nora Ventosa; Jaume Veciana; María J Blanco-Prieto
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

Review 3.  Nanomedicine as an emerging approach against intracellular pathogens.

Authors:  Andrea L Armstead; Bingyun Li
Journal:  Int J Nanomedicine       Date:  2011-12-09

4.  Brucella species-induced brucellosis: Antimicrobial effects, potential resistance and toxicity of silver and gold nanosized particles.

Authors:  Ayman Elbehiry; Musaad Aldubaib; Osamah Al Rugaie; Eman Marzouk; Ihab Moussa; Mohamed El-Husseiny; Mai Ibrahem; Adil Abalkhail; Mohammed Rawway
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

Review 5.  Tripping on acid: trans-kingdom perspectives on biological acids in immunity and pathogenesis.

Authors:  Michael F Criscitiello; Martin B Dickman; James E Samuel; Paul de Figueiredo
Journal:  PLoS Pathog       Date:  2013-07-18       Impact factor: 6.823

6.  Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice.

Authors:  Tsevelmaa N; Narangerel B; Odgerel O; Dariimaa D; Batkhuu J
Journal:  BMC Complement Altern Med       Date:  2018-05-03       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.